Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Pyxis Oncology received early financing of $22.0M on 2019-07-17.
| Series | Round size | Date |
|---|---|---|
| Series A | $22M | 07/2019 |
| Series B | $152M | 03/2021 |
| Investors | Security type |
|---|---|
| Agent Capital | Series A |
| Longwood Fund | Series A |
| Leaps by Bayer | Series A |
| IPSEN | Series A |
| RTW INVESTMENTS LP | Series B |
| BVF PARTNERS L P | Series B |
| LifeSci Venture Partners | Series B |
| Logos Capital | Series B |
| ARIX BIOSCIENCE PLC | Series B |
| Tekla Capital Management | Series B |
| Pfizer Venture Investments | Series B |
| Biotechnology Value Fund | Series B |
| Leaps by Bayer | Series B |
| IPSEN | Series B |
| Surveyor Capital | Series B |
| HBM Healthcare Investments AG | Series B |
| Ridgeback Capital | Series B |
| Agent Capital | Series B |
| Longwood Fund | Series B |
| Laurion Capital Management LP | Series B |
| Acuta Capital Partners | Series B |
| Cormorant Asset Management | Series B |
| Perceptive Advisors | Series B |
| Janus Henderson Investors | Series B |
| RA Capital Management | Series B |
Pyxis Oncology's top competitor, Bolt Biotherapeutics, earned an annual revenue of $7.7M.
Pyxis Oncology's smallest competitor is Trillium Therapeutics with revenue of $148.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Bolt Biotherapeutics | - | $7.7M | 91 | - |
| Leap Therapeutics | - | $1.5M | 30 | - |
| Eureka Therapeutics | - | $500,000 | 50 | - |
| Prelude Therapeutics | - | $7.0M | 70 | - |
| Trillium Therapeutics | - | $148,000 | 20 | - |
| Bellicum Pharmaceuticals | - | $1.5M | 16 | - |
Zippia gives an in-depth look into the details of Pyxis Oncology, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Pyxis Oncology. The employee data is based on information from people who have self-reported their past or current employments at Pyxis Oncology. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Pyxis Oncology. The data presented on this page does not represent the view of Pyxis Oncology and its employees or that of Zippia.
Pyxis Oncology may also be known as or be related to PYXIS ONCOLOGY, INC. and Pyxis Oncology.